Orthocell Ltd

Biotechnology ResearchWestern Australia, Australia51-200 Employees

Orthocell is a regenerative medicine company dedicated to the development of breakthrough products to unlock the power of the human body to heal - restoring mobility, function and performance. Its is listed on the Australian Stock Exchange (ASX:OCC).

Orthocell's research has led to the development of a number of regenerative medical products and devices from autologous cell therapies to collagen medical devices manufactured by Orthocell Ltd, in Perth Western Australia, using the proprietary SMRT™ manufacturing process.

Remplir™ is a sterile, resorbable collagen nerve wrap used by surgeons to assist in the repair and protection of peripheral nerve injuries. Remplir™ is approved for sale in multiple major markets around the World.

Striate+™ is a sterile, resorbable collagen membrane, primarily used in dental surgery to support guided bone regeneration (GBR) and guided tissue regeneration (GTR). It is distributed globally through a partnership with BioHorizons.

SmrtGraft™ is a sterile, bio-resorbable collagen scaffold used to augment the surgical repair of damaged or torn human tendon tissue.

OrthoACI™ (Autologous Chondrocyte Implantation) is a personalised cell therapy used to repair and regenerate damaged articular cartilage in joints, primarily in the knee and ankle. It uses a patient's own healthy tendon cells to stimulate regeneration and repair damaged tissue.

OrthoATI™ (Autologous Tenocyte Implantation) is a personalised cell therapy used to treat chronic, degenerative tendon injuries. It uses a patient's own healthy tendon cells to stimulate regeneration and repair damaged tissue.

Sign up for free to view info

Email Format Employee directory